Contact pathway of coagulation and inflammation

Abstract

The contact system, also named as plasma kallikrein-kinin system, consists of three serine proteinases: coagulation factors XII (FXII) and XI (FXI), and plasma prekallikrein (PK), and the nonenzymatic cofactor high molecular weight kininogen (HK). This system has been investigated actively for more than 50 years. The components of this system and their interactions have been elucidated from in vitro experiments, which indicates that this system is prothrombotic by activating intrinsic pathway, and proinflammatory by producing bioactive peptide bradykinin. Although the activation of the contact system have been implicated in various types of human disease, in only a few instances is its role clearly defined. In the last 10 years, our understanding of the contact system, particularly its biology and (patho)physiology has greatly increased through investigations using gene-modified animal models. In this review we will describe a revitalized view of the contact system as a critical (patho)physiologic mediator of coagulation and inflammation.

References 65

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1007/bf02737657

3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.2174/187152509789105444

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.4049/jimmunol.1302590

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1055/s-0031-1276586

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1016/j.cell.2009.11.001

7. 7.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1042/bst20130111

8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1111/j.1538-7836.2010.03893.x

9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1172/jci36617

10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2008-07-171066

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/nm.2295

12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/s0014-5793(01)02570-4

13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.bbagen.2006.10.015

14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1160/th10-01-0017

15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1161/atvbaha.107.148759

16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1161/01.atv.0000240290.70852.c0

17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.4049/jimmunol.175.5.3377

18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1111/j.1365-2958.1996.tb02534.x

19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1111/j.1538-7836.2010.03789.x

21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1097/00001721-199304000-00003

22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1097/01.mbc.0000224843.33216.5f

23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1084/jem.20050664

25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1084/jem.20052458

26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2010-02-270918

27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.bcmd.2005.12.014

28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1160/th11-10-0682

29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2011-05-355248

30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2007-06-092338

31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2012-06-440057

32. 32.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1111/j.1538-7836.2012.04758.x

33. 33.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1182/blood-2013-12-540872

34. 34.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1084/jem.20112322

35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1159/000203700

36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1084/jem.20091007

37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1160/th13-08-0668

38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1172/jci115416

39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1056/nejm199107183250303

40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1172/jci781

Cited by papers we hold 4

• Phage Display Derived Monoclonal Antibodies: From Bench to Bedside · 2020
  No notice
• Phenome-wide association studies across large population cohorts support drug target validation · 2018
  No notice
• Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility · 2018
  No notice
• The Role of Inflammation in Venous Thromboembolism · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.